Ontex Group N.V.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Laurent Nielly
- Full Time Employees
- 6,627
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Address
- Korte Keppestraat 21 Aalst Belgium 9320
- IPO Date
- Oct 7, 2020
- Website
- ontex.com
- Similar Companies
- Business
- Ontex Group NV (Euronext: ONTEX; OTC: ONXYY) develops, manufactures and supplies personal hygiene products for baby care, feminine care and adult care to retailers, institutional healthcare providers, private healthcare and consumers worldwide. The company offers baby care products including diapers, pants and wet wipes under brands such as Baby Pants, Bbtips, Bio Baby, Canbebe, Helen Harper, Kiddies, Little Big Change, Moltex, Pom Pom, Sapeka and Monica; feminine care products comprising sanitary towels, panty liners and tampons under brands including Fiore, Mia, NAT, Sincere and Silhouette; and adult incontinence products such as pants, diapers, towels and bed protection under brands like A Lovely Day, Adultmax Maturidade, Affective, Bigfral, iD, Canped, Liberty, Lille Healthcare, Kylie, Serenity, Orizon and Moviment, as well as retailer own brands. Ontex operates manufacturing facilities, R&D centers and sales offices across Europe and North America, with products available in more than 100 countries; it was founded in 1979 and is headquartered in Aalst, Belgium. In recent strategic changes, Ontex completed the divestment of its Brazilian business to Softys SA in early 2025 for approximately EUR110 million and its Turkish subsidiary to Dilek Grup in November 2025, marking the conclusion of its portfolio refocus on retail and healthcare brands in core markets of Europe and North America; these transactions generated around EUR115 million in proceeds to reduce indebtedness and support transformation initiatives, including intensified capital expenditures of EUR45 million in H1 2025 for North American expansion, cost programs and innovation. The company also closed its Eeklo plant in Belgium and transformed its Buggenhout facility into a center of excellence for incontinence care, funded by a EUR62 million provision, while reporting 3.5% like-for-like revenue growth to EUR1.86 billion and 28% adjusted EBITDA increase to EUR223 million in 2024 amid ongoing operational restructuring.
Ontex Group NV (ONXYY) Q1 2026 Earnings Call Transcript
Ontex Group NV (ONXYY) Q4 2025 Earnings Call Transcript
Ontex Group NV (ONXYY) Q3 2025 Earnings Call Transcript
Ontex Group NV (ONXXF) Q2 2025 Earnings Call Transcript
Ontex Group NV announces the redemption of the outstanding 3.500% senior notes due 2026
Ontex Group NV (ONXXF) Q1 2025 Earnings Call Transcript
Ontex Group NV announces the results of its cash tender offer for its outstanding €580,000,000 3.500% senior notes due 2026
Ontex Group NV announces pricing of €400 million senior notes
Ontex Group NV announces offering of €400 million senior notes
Ontex Group NV announces the launch of a cash tender offer for up to €400,000,000 aggregate principal amount of its outstanding €580,000,000 3.500% senior notes due 2026
Ontex Group NV (ONXXF) Q4 2024 Earnings Call Transcript
Ontex reaches binding agreement to sell its Turkish subsidiary to Dilek Grup
Ontex Group NV (ONXXF) Q3 2024 Earnings Call Transcript
Ontex Group NV (ONXXF) Q2 2024 Earnings Call Transcript
Ontex Group NV (ONXXF) Q1 2024 Earnings Call Transcript
Ontex Group NV (ONXXF) Q4 2023 Earnings Call Transcript
Ontex Group NV (ONXXF) Q3 2023 Earnings Call Transcript
Ontex Group NV (ONXXF) Q2 2023 Earnings Call Transcript
Ontex Group NV (ONXXF) Q1 2023 Earnings Call Transcript
Ontex Group NV (ONXXF) Q4 2022 Earnings Call Transcript